RBM39 and plasma cell myeloma: In myeloma, Tong et al. 44 revealed that hypoxia-induced lncRNA DARS-AS1 upregulates RBM39 protein expression via the ubiquitin-proteasome pathway, and further promotes mTOR signaling pathway to promote myeloma malignancy.